Navigation Links
This is no yarn …Talk your way to beauty sleep

Babbling in sleep is known to wake the deep in sleep, and there are many who are known to roam in sleep but the group that gets talked //about the most are those who lie awake in sleepless disquiet. Popularly called as insomniacs, these sufferers are willing to toss around money and pop in magic pills that promise blissful sleep.

A novel study, courtesy the Norwegian researchers, has revealed that talking sessions also called cognitive behavioral therapy, or CBT provides relief even to time-tested insomniacs, much better than sleeping pills. Essentially, CBT endeavors to alter certain behaviors and manner of thought flow, especially those that can impede sleep.

B?rge Sivertsen, PsyD, and colleagues at the University of Bergen in Norway unraveled the beneficial effects of this therapy when they studied 46 long-term insomniacs. The study groups were randomly administered CBT, Imovane, or placebo pills. Imovane is a commonly used sleep drug used in Europe, on the likes of Lunesta. The treatment was administered for six weeks. Six months after treatment, researchers gauged the sleep pattern of the group that underwent the treatment.

The finding revealed that the insomniacs who received CBT perceived a 10% reduction in the time spent on the bed awake, as against 20% before treatment. Importantly, this status improved six months after the treatment. There was no change in the sleeping pattern of sufferers who took the pill or placebo, who were awake in bed in just the same way as they were before the commencement of the study.

Expressing surprise, Sivertsen said "We expected CBT to be efficient, but we did not expect such strong differences between groups.”

CBT aficionado and director of the Kathryn Severyns Dement Sleep Disorders Center, Richard Simon Jr., MD, had the last word when he said "The main finding of this study is extraordinarily consistent with everything in the medical literature. The bottom line is that whenever one compares CBT to sleep medications, CBT is always at least as good if not better -- and, typically, the effect of CBT is longer lasting."

The study is published in the Journal of the American Medical Association.


'"/>




Related medicine news :

1. Women opt for liposuction to retain their beauty
2. Australian beauty with roots in India open to acting in Bollywood
3. Eyelash transplantation – for the beauty conscious folks!
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/26/2017)... ... May 26, 2017 , ... ... CareFusion NOX-T3 portable sleep monitor with its Somnoware Sleep Device Interface (SDI). Somnoware ... for diagnostic device operations. With this platform, initializing devices and importing studies are ...
(Date:5/26/2017)... Sparks, Nevada (PRWEB) , ... May 26, 2017 ... ... to produce the first ever copper, antimicrobial, mesh back 24/7 task chair specifically ... and conference applications. “We are thrilled to partner with Cupron® to provide ...
(Date:5/26/2017)... Texas (PRWEB) , ... May 26, 2017 , ... Yisrayl ... a new publication this week that is focusing on the Peace Agreements being discussed ... his Middle East sprint in a race to try to speed up peace talks ...
(Date:5/26/2017)... Francisco, CA (PRWEB) , ... May 26, 2017 , ... ... Francisco, is proud to announce a new, informational blog post on insurance options. If ... surgery, checking insurance plans may help save time and money. Visiting an in-network provider ...
(Date:5/26/2017)... ... 26, 2017 , ... Centennial-based BluSky Restoration Contractors announced that ... Annual Clays for Kids fundraiser, to be held Friday, Sept. 22, at Kiowa ... part of BluSky’s partnership with The Adoption Exchange, BluSky will also share sponsorship ...
Breaking Medicine News(10 mins):
(Date:5/18/2017)...  Two Bayer U.S. Pharmaceutical leaders received top awards ... 28 th Woman of the Year ... longstanding mission of furthering the advancement and impact of ... Cindy Powell-Steffen , senior director of brand activation and ... Libby Howe , a regional business manager for New ...
(Date:5/15/2017)... Inc., a privately-held CNS pharmaceutical company based in ... disease (PD), has enrolled the first patient in the RASMET ... study involving patients with PD and taking place at 12 ... period. The first stage is open label and involves single ... Denver , Boca Raton ...
(Date:5/10/2017)... Inc. (Nasdaq: HOLX ) announced today the ... April 1, 2017 .   GAAP diluted earnings per ... prior year period as the sale of the blood ... diluted EPS of $0.50 increased 6.4%.  Revenue of $715.4 ... Excluding the effects of blood screening and the acquired ...
Breaking Medicine Technology: